Tofacitinib Citrate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tofacitinib Citrate
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Tofacitinib Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 29 USDMF, 1 JDMF, 7 EU WC, 22 KDMF, 25 NDC API, 53 Listed Suppliers, $ API Reference Price

68 API Suppliers
29 USDMF
1 JDMF
7 EU WC
22 KDMF
25 NDC API
53 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

59 API Suppliers

59 API Suppliers

FINISHED DOSAGE FORMULATIONS

68 FDF Dossiers, 18 FDA Orange Book, 4 Europe, 9 Canada, 17 Australia, 1 South Africa, 19 Listed Dossiers

68 FDF Dossiers
18 FDA Orange Book
4 Europe
9 Canada
17 Australia
1 South Africa
19 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 3 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 5 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 19 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

1 Rochem International Inc
3 SPI Pharma
3 DKSH
1 Jai Radhe Sales
2 Boai NKY Pharmaceuticals Ltd
10 Gangwal Healthcare
4 Nanjing Well Pharmaceutical
1 Alcedo Pharmachem
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 BASF
5 DFE Pharma
1 Finar
4 Gangwal Chemicals
1 Huzhou Sunflower Pharmaceutical
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
10 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
19 Roquette
1 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
10 Sigachi Industries
1 Valens Pharmachem
3 Vasa Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 24 Direct Compression, 18 Film Formers & Plasticizers, 14 Disintegrants & Superdisintegrants, 12 Granulation, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Thickeners and Stabilizers, 11 Coating Systems & Additives, 8 Taste Masking, 5 Controlled & Modified Release, 5 Parenteral, 4 Solubilizers, 4 Topical, 4 Chewable & Orodispersible Aids, 3 Coloring Agents, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 Soft Gelatin

52 Fillers, Diluents & Binders
24 Direct Compression
18 Film Formers & Plasticizers
14 Disintegrants & Superdisintegrants
12 Granulation
12 Co-Processed Excipients
11 Lubricants & Glidants
11 Thickeners and Stabilizers
11 Coating Systems & Additives
8 Taste Masking
5 Controlled & Modified Release
5 Parenteral
4 Solubilizers
4 Topical
4 Chewable & Orodispersible Aids
3 Coloring Agents
2 Rheology Modifiers
2 Emulsifying Agents
1 Soft Gelatin

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 196 NEWS #PharmaBuzz

8 DATA COMPILATION #PharmaFlow
196 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
2 Finished Drug Prices
10 Annual Reports

MARKET PLACE

21 APIs, 2 FDF Dossiers

21 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 US Patents, 3 US Exclusivities, 3 Health Canada Patents

15 US Patents
3 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

24 Others

24 Others

$ API Ref.Price (USD/KG) : 16,069 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Pfizer Canada ULC

filter Patent Reset all filters

3 All

01 12393640

02 12448281

03 12469350

filter Product Reset all filters

3 All

01 3TOFACITINIB CITRATE

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 12020-11-23

02 12022-05-29

03 12022-11-25

Minakem Tofacitinib Citrate

Product Main Page

01

Pfizer Canada ULC

Tofacitinib Citrate

2024 ACI Convention

Not Confirmed

Pfizer Canada ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-11-25

Date Granted : 2009-09-29

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2469350

Filing Date : 2002-11-25

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-11-25

Date Granted : 2009-09-29

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Tofacitinib Citrate

2024 ACI Convention

Not Confirmed

Pfizer Canada ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-05-29

Date Granted : 2009-05-05

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2448281

Filing Date : 2002-05-29

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-05-29

Date Granted : 2009-05-05

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Tofacitinib Citrate

2024 ACI Convention

Not Confirmed

Pfizer Canada ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-11-23

Date Granted : 2006-09-05

Tofacitinib Citrate

Brand Name : XELJANZ

Patent Number : 2393640

Filing Date : 2000-11-23

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2020-11-23

Date Granted : 2006-09-05

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?